Reflections Treatment Center: New Samples, Unread Results

The clinical director of Reflections Treatment Center and Journey to Recovery admitted that drug tests did not direct patients’ treatment. The Justice Department’s April 2017 criminal-case announcement described his separate guilty plea to conspiring to commit health care fraud and falsifying a matter involving health care benefit programs. He was a licensed mental health counselor responsible for supervising clinical services at both centers.

The centers’ owner’s referral-payment scheme is the subject of our separate account of the Reflections and Journey to Recovery owners.

What the Tests Were Supposed to Do

Urine drug testing gives a treatment team information it can use to assess substance use and support recovery. The clinical work includes choosing the test, interpreting the result and deciding what it means for that patient’s care.

The 2021 Journal of Family Practice review Urine Drug Screening: A Guide to Monitoring Tx With Controlled Substances describes drug testing as:

The review describes how an expected result can reinforce a patient’s progress. An unexpected screening result calls for interpretation and, where needed, confirmation before a significant clinical decision.

When the Clinical Director’s Recommendation Lost to Billing

According to the criminal-case announcement, the clinical director knew about the hidden ownership of the businesses and kickbacks disguised as service fees. He admitted that the testing was useless for directing treatment, while as many as 90% of patients tested positive for continued drug use.

When he recommended detoxification or another facility for some patients who had relapsed, the owner overruled him because discharging them would end the insurance billing. The clinical recommendation and the decision to keep a patient supplied different answers to the same question: what should happen next?

The announcement also described the director’s consulting business. His firm helped treatment facilities obtain licenses, and he filed licensing documents and assisted with audits for Reflections and Journey to Recovery. His role therefore reached both clinical supervision and the paperwork supporting the centers’ operation.

The Order, Result and Claim

Laboratory billing separates work that a patient experiences as a single course of care. In the Medicare workflow, the treating physician or qualified practitioner orders the test and keeps the medical justification. The laboratory performs the service, reports the result and submits its claim. The information supporting payment can therefore sit in the treatment center while the bill comes from the laboratory.

Medicare’s diagnostic testing requirements connect the ordering practitioner to use of the results in managing the patient’s specific medical problem. The billing entity must keep what it received from the ordering practitioner and documentation that its claim accurately reflects that information.

For an insider, this explains why the requisition and the chart can tell different stories. The requisition identifies the requested testing. The clinical record explains the patient’s problem and the reason for that testing. The returned result and subsequent assessment show how the information entered care.

Our work connects those accounts. A laboratory employee may know what arrived on the order and what was billed. A counselor or clinical director may know whether anyone discussed the result or used it in the patient’s plan.

When Are Toxicology Tests Unnecessary?

Toxicology tests can be unnecessary when the testing has no patient-specific clinical purpose, or when a routine keeps generating tests beyond what the patient’s care calls for. The Journal of Family Practice review describes excessive frequency, large expensive panels and unnecessary confirmatory analysis among practices that have contributed to insurance fraud.

Its addiction-treatment discussion also explains why frequency matters clinically. Testing and visits can become less frequent as a patient’s condition improves and more frequent when substance use increases. It describes testing at every visit as often unnecessary for stable patients. The patient’s course supplies the reason for the schedule.

That helps explain the significance of the clinical director’s admissions. Testing continued while its results failed to guide care. The gap between the schedule and the clinical assessment is something a person inside the program can explain with far more precision than a total test count.

A Sober-Home Rule Is Not a Treatment Plan

The distinction also appears in civil laboratory cases. GENCO Lab agreed to a $1,255,825 settlement announced in August 2025 over allegations that included urine testing for sober-home residents solely for residential monitoring, along with duplicative testing.

That parallel concerns why testing was done. A residence may want to monitor sobriety, while a medical claim depends on the clinical purpose of the service being billed. In the clinical director’s account, the results were not directing treatment. In the GENCO civil allegations, residential monitoring supplied the purpose. Both make the reason behind a recurring test more revealing than the fact that someone supplied a specimen.

For a healthcare insider, the useful detail is where the decision came from: the patient’s assessment, a facility routine or a financial arrangement. Orders, result-review records and treatment notes let us examine that question with you. We connect what you saw in clinical work to the health care services billed and the people making those decisions.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Know Where the Results Went

If you saw testing continue while results went unread or clinical decisions gave way to billing demands, talk with our whistleblower experts about what happened inside the program. We work with you to build the case around that clinical knowledge and bring in laboratory fraud whistleblower lawyers who understand addiction-treatment testing. We stay beside you as the case moves from your account of patient care to the pursuit of a recovery.